V. Samuel

Epidemiology · 2004–2017

A researcher in the Science corpus: 9 papers; trusts 34 researchers and is trusted by 5 researchers here, as inferred from the citation graph.

Subfields

• Epidemiology — 96 citations into it; #869 of 2,148 by trust here, #549 by citations
• Molecular Biology — 88 citations into it; #7,506 of 17,773 by trust here, #4,510 by citations
• Physiology — 80 citations into it; #782 of 2,276 by trust here, #1,048 by citations
• Endocrinology, Diabetes and Metabolism — 51 citations into it; #432 of 623 by trust here, #193 by citations
• Surgery — 41 citations into it; #264 of 1,106 by trust here, #314 by citations
• Biochemistry — 28 citations into it; #92 of 547 by trust here, #92 by citations
• Cell Biology — 15 citations into it; #580 of 2,073 by trust here, #960 by citations
• Cardiology and Cardiovascular Medicine — 13 citations into it

Whom V. Samuel trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. K. Petersen
2. Judea Pearl
3. S. Dufour
4. S. Weisberg
5. D. Guertin
6. Gerald I. Shulman
7. D. Befroy
8. Ann-Hwee Lee
9. G. Targher
10. William L. Holland

Who trusts V. Samuel overall

1. Gerald I. Shulman
2. Haiming Cao
3. Max C. Petersen
4. M. Kotas
5. Habib Yaribeygi
6. R. Medzhitov
7. R. Loomba
8. K. Petersen
9. Christopher D. Byrne
10. Andreas L. Birkenfeld

Papers from V. Samuel's perspective

Ordered by how strongly the researchers V. Samuel trusts endorse each paper. Same corpus, a different order for every researcher.

1. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* (Journal of Biological Chemistry)
2. Obesity is associated with macrophage accumulation in adipose tissue. (Journal of Clinical Investigation)
3. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. (Journal of Clinical Investigation)
4. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity (Nature Medicine)
5. The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes. (Diabetes)
6. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. (Journal of Clinical Investigation)
7. Molecular mediators of hepatic steatosis and liver injury. (Journal of Clinical Investigation)
8. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. (Cell Metabolism)
9. TLR4 links innate immunity and fatty acid-induced insulin resistance. (Journal of Clinical Investigation)
10. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. (Cell)

Their papers

• Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* (2004) — 1,356 citations
• Lipid-induced insulin resistance: unravelling the mechanism (2010) — 1,162 citations
• Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase (2014) — 1,208 citations
• Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice (2010) — 719 citations
• The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. (2016) — 1,184 citations
• FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis (2011) — 608 citations
• Non-Alcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases (2017) — 657 citations
• The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes (2014) — 1,068 citations
• Integrating Mechanisms for Insulin Resistance: Common Threads and Missing Links (2012) — 2,256 citations